Skip to main content
Premium Trial:

Request an Annual Quote

NCI Awards $11M for Biomarker Studies Under Early Detection Research Network

NEW YORK, May 13 (GenomeWeb News) - The National Cancer Institute has awarded 13 grants worth a total of $11 million to fund research for the next five years under its Early Detection Research Network, the agency said yesterday.

 

Four of the grants go to institutions not previously funded by EDRN, whose goal is to establish validated biological markers that are ready for large-scale clinical testing. The funding covers three of the network's four components: clinical epidemiology and validation centers, biomarker reference laboratories, and a data management and coordinating center, as well as an informatics center. Funding for the fourth component, biomarker development laboratories, was awarded late last year.

 

Funding for epidemiology and validation centers goes to the Universityof Michigan, Brigham and Women's Hospital, the FoxChaseCancerCenter, CreightonUniversityin Omaha, Johns Hopkins University, New YorkUniversity School of Medicine, BethIsraelDeaconessMedicalCenter, University of Texas Health Science Center, and the Centers for Disease Control and Prevention.

 

Biomarkers reference laboratories funding was awarded to the National Institute of Standards and Technology, JohnsHopkinsUniversity, the Universityof California, Los Angeles, the Universityof Alabama, and the Universityof Maryland.

 

The FredHutchinsonCancerCenterreceived funding for the data management and coordinating center, and the National Aeronautics and Space Administration California Institute of Technology for the informatics center.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.